US2007043283A1PendingUtilityA1
Method and Apparatus for Non-Invasive Monitoring of Blood Substances Using Self-Sampled Tears
Est. expiryApr 5, 2022(expired)· nominal 20-yr term from priority
Inventors:Bruce E. CohanGeun Sig ChaMark E. MeyerhoffHakhyun NamDonald E. GillespieGang CuiJong Sik KimZvi Flanders
C12Q 1/006G01N 2001/1056C12Q 1/54Y10T436/144444A61B 5/1486G01N 33/528G01N 2001/149G01N 27/3272C12Q 1/32G01N 2035/0465A61B 2562/0295
60
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method and apparatus for non-invasively determining the concentration of a substance in blood, such as glucose, include a sample portion arranged for contacting an eye region of a user to obtain a tear fluid sample, a sensor in communication with the sample portion for generating a signal related to the tear substance concentration, and a processor in communication with the sensor for determining a blood substance concentration corresponding to the tear substance concentration.
Claims
exact text as granted — not AI-modified1 . An apparatus for determining the concentration of a substance in blood, the apparatus comprising:
a housing; a test probe arranged to be received within the housing, the test probe arranged to engage an eye region of a user to obtain a tear fluid sample while the test probe is received within the housing; a sensor disposed within the housing in communication with the test probe for generating a signal related to the tear substance concentration; and a processor disposed within the housing in communication with the sensor for determining a blood substance concentration corresponding to the tear substance concentration.
2 . The apparatus according to claim 1 , wherein the substance includes glucose.
3 . The apparatus according to claim 2 , wherein the sensor is operable to detect glucose concentrations less than about 20 mg/dL with a resolution of at least 5 mg/dL.
4 . The apparatus according to claim 1 , wherein the test probe is arranged to allow self-sampling of the tear fluid sample by a user.
5 . The apparatus according to claim 1 , wherein the test probe includes an inlet extending outwardly therefrom.
6 . The apparatus according to claim 5 , wherein the inlet includes a capillary member or a wicking membrane.
7 . The apparatus according to claim 1 , wherein a volume of the tear fluid sample held by the test probe is less than about 0.5 μL.
8 . The apparatus according to claim 1 , wherein the test probe is removable from the housing.
9 . The apparatus according to claim 1 , further comprising a display screen in communication with the processor for displaying the blood substance concentration.
10 . The apparatus according to claim 1 , further comprising memory in communication with the processor for storing the blood substance concentration.
11 . The apparatus according to claim 1 , wherein the housing is generally pen-shaped.
12 . The apparatus according to claim 1 , wherein the test probe includes an enzyme for reacting with the substance in the tear fluid sample.
13 . The apparatus according to claim 12 , wherein the enzyme includes glucose dehydrogenase.
14 . The apparatus according to claim 12 , wherein the test probe includes an electrode system provided therein, the apparatus further comprising a power source for applying a voltage to the electrode system to induce an electrochemical reaction of the enzyme and the substance, and wherein the sensor detects a current resulting from the electrochemical reaction and the processor determines a tear substance concentration from the detected current.
15 . The apparatus according to claim 1 , wherein the apparatus is configured to allow the electronic transfer of substance concentration data.
16 . An apparatus for determining glucose concentration in a tear fluid sample, the apparatus comprising:
a housing; a test probe arranged to be received within the housing, the test probe arranged to engage an eye region of a user to obtain a tear fluid sample while the test probe is received within the housing; a sensor disposed within the housing in communication with the test probe for generating a signal related to the glucose concentration in the tear fluid sample; and a processor in communication with the sensor for processing the signal to determine the tear glucose concentration.
17 . An apparatus for determining glucose concentration in blood, the apparatus comprising:
a housing; a test probe arranged to be received within the housing, the test probe having an inlet arranged to engage an eye region of a user to obtain a tear fluid sample while the test probe is received within the housing, the test probe having an enzyme provided therein for initiating a reaction with the tear fluid sample, wherein a volume of the tear fluid sample held by the test probe is less than about 0.5 μL; a sensor disposed within the housing in communication with the test probe for detecting a signal generated by the reaction; a processor in communication with the sensor for determining a tear glucose concentration from the detected signal and correlating the determined tear glucose concentration with a blood glucose concentration; and means for providing an output indicative of the blood glucose concentration.
18 . The apparatus according to claim 17 , wherein the test probe is arranged to allow self-sampling of the tear fluid sample by a user.
19 . The apparatus according to claim 17 , wherein the housing is generally pen-shaped.
20 . The apparatus according to claim 17 , wherein the sensor is operable to detect glucose concentrations less than about 20 mg/dL with a resolution of at least 5 mg/dL.
21 . The apparatus according to claim 17 , wherein the enzyme includes glucose dehydrogenase.
22 . The apparatus according to claim 17 , wherein the test probe includes pyrrolo-quinoline-quinone as a coenzyme.
23 . The apparatus according to claim 17 , wherein the test probe includes an electron transfer mediator.
24 . The apparatus according to claim 23 , wherein the electron transfer mediator includes a ruthenium complex.
25 . The apparatus according to claim 23 , wherein the test probe includes a base plate, a cover plate, and a spacer disposed between and joining the base and cover plates, the base and cover plates including a converse-type electrode system, the apparatus further comprising a power source for applying a voltage to the electrode system to induce an electrochemical reaction of the enzyme and the electron transfer mediator with glucose in the tear fluid sample and generate a current related to tear glucose concentration.
26 . The apparatus according to claim 25 , wherein the processor determines a tear glucose concentration from the generated current and multiplies the tear glucose concentration by a calibration factor to determine the corresponding blood glucose concentration.
27 . The apparatus according to claim 17 , further comprising a speaker in communication with the processor.
28 . The apparatus according to claim 17 , wherein the apparatus is configured to allow the electronic transfer of glucose concentration data.Join the waitlist — get patent alerts
Track US2007043283A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.